GlassScriptPhysician profile
Lynn M Koehler
NPI 1083606628
$3,046.41
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,559 · 2020: $413 · 2021: $51.57 · 2022: $22.92.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $371.07 | 2019 | |
| Janssen Pharmaceuticals, INC | $304.21 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $302.54 | 2019 | |
| Novo Nordisk INC | $285.44 | 2019 | |
| Pfizer INC. | $279.32 | 2019-2020 | |
| Amarin Pharma, INC. | $223.85 | 2019-2020 | |
| Allergan, INC. | $207.50 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.18 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $155.21 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $146.80 | 2019 | |
| Sunovion Pharmaceuticals INC. | $115.94 | 2019-2020 | |
| Lilly USA, LLC | $86.44 | 2019-2020 | |
| Mylan Specialty L.P. | $77.14 | 2019-2020 | |
| Astellas Pharma US INC | $63.24 | 2019 | |
| Merck Sharp & Dohme LLC | $52.32 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $52.20 | 2019 | |
| Abbvie INC. | $51.57 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $37.73 | 2019-2020 | |
| Glaxosmithkline, LLC. | $26.20 | 2019 | |
| Boston Scientific Corporation | $22.92 | 2022 | |
| Horizon Therapeutics Plc | $20.59 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Koehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.